BlackRock’s Acer Therapeutics Inc ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-76,772
| Closed | -$62.6K | – | 5520 |
|
|
2023
Q3 | $62.6K | Hold |
76,772
| – | – | ﹤0.01% | 4962 |
|
|
2023
Q2 | $70.9K | Sell |
76,772
-26,200
| -25% | -$23.2K | ﹤0.01% | 5005 |
|
|
2023
Q1 | $78.1K | Sell |
102,972
-16,048
| -13% | -$31.7K | ﹤0.01% | 5027 |
|
|
2022
Q4 | $299K | Buy |
119,020
+194
| +0.2% | +$333 | ﹤0.01% | 4744 |
|
|
2022
Q3 | $166K | Sell |
118,826
-1,279
| -1% | -$1.85K | ﹤0.01% | 5026 |
|
|
2022
Q2 | $151K | Buy |
120,105
+17,065
| +17% | +$35.7K | ﹤0.01% | 5112 |
|
|
2022
Q1 | $300K | Sell |
103,040
-1,269
| -1% | -$3.06K | ﹤0.01% | 5017 |
|
|
2021
Q4 | $237K | Buy |
104,309
+705
| +0.7% | +$1.64K | ﹤0.01% | 5071 |
|
|
2021
Q3 | $265K | Sell |
103,604
-564
| -0.5% | -$1.43K | ﹤0.01% | 4917 |
|
|
2021
Q2 | $299K | Buy |
104,168
+10,530
| +11% | +$30.3K | ﹤0.01% | 4813 |
|
|
2021
Q1 | $291K | Hold |
93,638
| – | – | ﹤0.01% | 4680 |
|
|
2020
Q4 | $245K | Hold |
93,638
| – | – | ﹤0.01% | 4447 |
|
|
2020
Q3 | $270K | Sell |
93,638
-73,158
| -44% | -$236K | ﹤0.01% | 4356 |
|
|
2020
Q2 | $573K | Sell |
166,796
-222,930
| -57% | -$629K | ﹤0.01% | 4180 |
|
|
2020
Q1 | $775K | Sell |
389,726
-3,178
| -0.8% | -$11.6K | ﹤0.01% | 3948 |
|
|
2019
Q4 | $1.58M | Sell |
392,904
-7,593
| -2% | -$25.8K | ﹤0.01% | 3856 |
|
|
2019
Q3 | $1.28M | Buy |
400,497
+68,944
| +21% | +$202K | ﹤0.01% | 3895 |
|
|
2019
Q2 | $1.29M | Buy |
331,553
+311,590
| +1,561% | +$5.94M | ﹤0.01% | 3933 |
|
|
2019
Q1 | $485K | Buy |
19,963
+10,055
| +101% | +$237K | ﹤0.01% | 4105 |
|
|
2018
Q4 | $199K | Sell |
9,908
-683
| -6% | -$15.7K | ﹤0.01% | 4236 |
|
|
2018
Q3 | $327K | Buy |
10,591
+2,805
| +36% | +$75.1K | ﹤0.01% | 4220 |
|
|
2018
Q2 | $168K | Buy |
7,786
+7,418
| +2,016% | +$141K | ﹤0.01% | 4355 |
|
|
2018
Q1 | $7K | Hold |
368
| – | – | ﹤0.01% | 4692 |
|
|
2017
Q4 | $5K | Hold |
368
| – | – | ﹤0.01% | 4731 |
|
|
2017
Q3 | $7K | Buy |
368
+30
| +9% | +$291 | ﹤0.01% | 4718 |
|
|
2017
Q2 | $2K | Buy |
338
+49
| +17% | +$325 | ﹤0.01% | 4923 |
|
|
2017
Q1 | $2K | Buy |
+289
| New | +$2.84K | ﹤0.01% | 4909 |
|
Other funds holding ACER
BlackRock's ACER Position: Q4 2023 in Review
BlackRock sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 76,772 shares — an estimated $62.6K sold.
BlackRock first reported a position in ACER in Q1 2017 and held it in 27 quarters. The position peaked at $1.58M in Q4 2019. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.
- BlackRock reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
- BlackRock sold 76,772 Acer Therapeutics Inc shares in Q4 2023, an estimated $62.6K.
- BlackRock first reported a position in Acer Therapeutics Inc in Q1 2017 and held it in 27 quarters.
- BlackRock's Acer Therapeutics Inc position peaked at $1.58M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.
Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.